EA200500387A1 - Композиции для ингаляции с высоким содержанием лекарственных веществ - Google Patents

Композиции для ингаляции с высоким содержанием лекарственных веществ

Info

Publication number
EA200500387A1
EA200500387A1 EA200500387A EA200500387A EA200500387A1 EA 200500387 A1 EA200500387 A1 EA 200500387A1 EA 200500387 A EA200500387 A EA 200500387A EA 200500387 A EA200500387 A EA 200500387A EA 200500387 A1 EA200500387 A1 EA 200500387A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
inhalation
high content
medicinal substances
microns
Prior art date
Application number
EA200500387A
Other languages
English (en)
Other versions
EA007375B1 (ru
Inventor
Ксиан-Минг Зенг
Original Assignee
Нортон Хелткэа Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нортон Хелткэа Лтд. filed Critical Нортон Хелткэа Лтд.
Publication of EA200500387A1 publication Critical patent/EA200500387A1/ru
Publication of EA007375B1 publication Critical patent/EA007375B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение предоставляет сухую порошковую композицию для ингаляции, содержащую по меньшей мере 0,25% по весу от всей композиции активного ингредиента с размером частиц диаметром менее 10 мкм и фармацевтически приемлемый носитель в виде частиц с размером частиц диаметром менее 250 мкм. Описаны также способы применения композиций данного изобретения с ингаляторами для сухого порошка для терапевтического лечения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500387A 2002-08-21 2003-08-21 Композиции для ингаляции с высоким содержанием лекарственных веществ EA007375B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0219511.3A GB0219511D0 (en) 2002-08-21 2002-08-21 Method of preparing dry powder inhalation compositions
PCT/US2003/026541 WO2004017942A1 (en) 2002-08-21 2003-08-21 Inhalation compositions with high drug ratios

Publications (2)

Publication Number Publication Date
EA200500387A1 true EA200500387A1 (ru) 2005-12-29
EA007375B1 EA007375B1 (ru) 2006-10-27

Family

ID=9942744

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500387A EA007375B1 (ru) 2002-08-21 2003-08-21 Композиции для ингаляции с высоким содержанием лекарственных веществ

Country Status (18)

Country Link
US (2) US8075873B2 (ru)
EP (1) EP1560567A4 (ru)
JP (1) JP2006517178A (ru)
KR (1) KR20050088276A (ru)
CN (1) CN101426476A (ru)
AU (1) AU2003260049B2 (ru)
BR (1) BRPI0313645A2 (ru)
CA (1) CA2499280A1 (ru)
DK (1) DK1545634T3 (ru)
EA (1) EA007375B1 (ru)
ES (1) ES2395261T3 (ru)
GB (1) GB0219511D0 (ru)
MX (1) MXPA05001901A (ru)
NO (1) NO20051463L (ru)
NZ (1) NZ538963A (ru)
TN (1) TNSN05048A1 (ru)
WO (1) WO2004017942A1 (ru)
ZA (1) ZA200502172B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
AU2004249166B2 (en) 2003-06-13 2008-10-09 Alkermes, Inc. Low dose pharmaceutical powders for inhalation
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
CA2562386C (en) 2004-04-21 2014-11-18 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
CN104644618A (zh) * 2013-11-19 2015-05-27 上海医药工业研究院 一种干粉吸入剂及其制备方法
JP6251667B2 (ja) 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US10898494B2 (en) 2016-05-05 2021-01-26 Liquidia Technologies, Inc. Dry powder treprostinil for the treatment of pulmonary hypertension

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3994974A (en) 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
IN166447B (ru) 1985-11-27 1990-05-12 Ethicon Inc
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
NZ246050A (en) 1991-12-18 1995-12-21 Astra Ab Formerly Aktiebolaget Medicament containing formoterol and budesonide for treatment of respiratory disorders
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
SE9700136D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US6103270A (en) 1996-06-07 2000-08-15 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
EP0952821A4 (en) 1996-12-31 2006-07-26 Nektar Therapeutics METHODS FOR DRYING AQUEOUS SUSPENSION OF HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS AND COMPOSITIONS PREPARED THEREFROM
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP0876814A1 (en) 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
US20030118514A1 (en) 1998-03-26 2003-06-26 Glaxo Wellcome Inc. Compositions for inhalation
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US5965622A (en) * 1998-06-23 1999-10-12 Sepracor Inc. Desformoterol and process for its preparation
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
IT1309592B1 (it) 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
SI1158958T1 (sl) 1999-03-05 2007-10-31 Chiesi Farma Spa Izboljĺ ani praĺ kasti farmacevtski sestavki za inhalacijo
US20020081266A1 (en) 1999-08-20 2002-06-27 Norton Healthcare Ltd. Spray dried powders for pulmonary or nasal administration
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
WO2001051030A1 (en) 2000-01-10 2001-07-19 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
US6369115B1 (en) 2000-03-20 2002-04-09 Dura Pharmaceuticals, Inc. Stabilized powder formulations
GB0009584D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
KR100488644B1 (ko) 2000-10-12 2005-05-11 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 티오트로퓸을 함유하는 신규 흡입용 산제
US20050158248A1 (en) 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US8273331B2 (en) 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
GB0219512D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
DE602004031459D1 (de) 2003-09-02 2011-03-31 Norton Healthcare Ltd Verfahren zur herstellung eines medikaments
EP1699435A4 (en) 2003-09-18 2009-05-20 Norton Healthcare Ltd PARTICLE

Also Published As

Publication number Publication date
EP1560567A1 (en) 2005-08-10
NO20051463L (no) 2005-05-20
WO2004017942A1 (en) 2004-03-04
US8075873B2 (en) 2011-12-13
US20090264389A1 (en) 2009-10-22
WO2004017942A8 (en) 2005-06-30
ES2395261T3 (es) 2013-02-11
MXPA05001901A (es) 2005-04-28
JP2006517178A (ja) 2006-07-20
TNSN05048A1 (en) 2007-05-14
NZ538963A (en) 2008-03-28
ZA200502172B (en) 2006-05-31
EA007375B1 (ru) 2006-10-27
GB0219511D0 (en) 2002-10-02
CA2499280A1 (en) 2004-03-04
AU2003260049A1 (en) 2004-03-11
KR20050088276A (ko) 2005-09-05
CN101426476A (zh) 2009-05-06
AU2003260049B2 (en) 2009-09-10
US20120065175A1 (en) 2012-03-15
BRPI0313645A2 (pt) 2017-12-12
EP1560567A4 (en) 2007-08-22
DK1545634T3 (da) 2012-11-19

Similar Documents

Publication Publication Date Title
TNSN05048A1 (en) Inhalation compositions with high drug ratios
HUP0300499A2 (en) Pharmaceutical formulations for dry powder inhalers
DE60104399D1 (de) Pulverformulierung zur inhalation
RU2014114221A (ru) Композиции и способы доставки фармакологических агентов
ATE556704T1 (de) Pulverinhalator-formulierungen
JO2430B1 (en) Pharmaceutical formulas for dry powder inhalations in the form of solid pellets
BR9915095A (pt) Composição farmacêutica ministrável em aerosol
BRPI0508170A (pt) formulações farmacêuticas para inaladores de pó seco, que compreendem um ingrediente ativo de potência de baixa dosagem
CY1106817T1 (el) Βελτιωμενες κονιωδεις φαρμακευτικες συνθεσεις για εισπνοη
FI956228A (fi) Sisäänhengitykseen tarkoitettuja koostumuksia
EA200101005A1 (ru) Высокоэффективные композиции, содержащие дигидроэрготамин
MY115688A (en) Pharmaceutical composition for administration by inhalation
WO2005025535A8 (en) Methods for preparing pharmaceutical compositions
NO20015082L (no) Pulverinnåndingsapparat for kombinert medikament
CY1110625T1 (el) Μεθοδος για την χορηγηση τιοτροπιου
MXPA05009629A (es) Composiciones que contienen trospio.
BRPI0313764A2 (pt) método de preparação de composições de inalação de pó seco
IL101056A (en) Composition for nasal treatment
SE0402345D0 (sv) A metered medication dose
IL142276A0 (en) Spray coated microparticles for use in needleless syringes
ATE520405T1 (de) Inhalationszusammensetzung
CA2499273A1 (en) Inhalation compositions
WO2005041922A3 (en) Composition
PL365736A1 (en) Bimodal dry powder formulation for inhalation
BG98927U (bg) АЕРОЗОЛНА ЛЕКАРСТВЕНА ФОРМА НА БАЗА АЛФА'-/(ТЕТРА-БУТИЛАМИНО)- МЕТИЛ/-4-ХИДРОКСИ-m-КСИЛЕН-АЛФА,АЛФА'-ДИОЛ СУЛФАТ (АСТМАЗОЛ)

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU